MDGL - MADRIGAL PHARMACEUTICALS, INC.

QQQ $ 610.94 $ -0.16 (-0.03 %)

DIA $ 469.35 $ 2.20 (0.47 %)

SPY $ 671.29 $ -0.01 (0 %)

TLT $ 92.00 $ 0.45 (0.49 %)

GLD $ 379.30 $ -25.91 (-6.43 %)

Previous Close

$ 430

Open

$ 440.68

Bid

$ 430.00 x 1

Ask

$ 447.00 x 25

Day's Range

$ 427.06 - $ 445.06

52 Week Range

$ 200.63 - $ 463.63

Volume

249,787

Average Volume

Market Cap

9.58B

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-26-2025	12-31-2024	10-K
4	10-31-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-06-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	02-23-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	02-25-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-26-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	02-27-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	03-13-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-11-2017	03-31-2017	10-Q
35	03-31-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	07-20-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	03-15-2016	12-31-2015	10-K
40	11-05-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Beyond The Numbers: 10 Analysts Discuss Ma...
10/15/2025 14:01:11

Piper Sandler Maintains Overweight on Madr...
10/15/2025 13:59:42

Piper Sandler analyst Yasmeen Rahimi maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Overweight and raises the price...

Truist Securities Initiates Coverage On Ma...
10/15/2025 11:35:28

Truist Securities analyst Srikripa Devarakonda initiates coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy ratin...

Oppenheimer Maintains Outperform on Madrig...
10/10/2025 17:51:53

Oppenheimer analyst Jay Olson maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform and raises the price target...

6-stocks-goldman-sachs-says-are-poised-for-potential-acquisition-in-next-12-months--including-a-huge-200-winner

6 Stocks Goldman Sachs Says Are Poised For...
09/30/2025 13:11:43

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

A Glimpse Into The Expert Outlook On Madri...
09/29/2025 21:01:08

In the latest quarter, 7 analysts provided ratings for Madrigal Pharmaceuticals (NASDAQ: MDGL), showcasing a mix of bullish and...

B. Riley Securities Maintains Buy on Madri...
09/29/2025 14:35:05

B. Riley Securities analyst Mayank Mamtani maintains Madrigal Pharmaceuticals (NASDAQ: MDGL) with a Buy and raises the price...

general-motors-to-rally-more-than-24-here-are-10-top-analyst-forecasts-for-friday

General Motors To Rally More Than 24%? Her...
09/12/2025 13:29:52

A Glimpse Into The Expert Outlook On Madri...
09/12/2025 13:01:34

Canaccord Genuity Maintains Buy on Madriga...
09/12/2025 12:56:28

Canaccord Genuity analyst Edward Nash maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price targe...

HC Wainwright & Co. Assumes Madrigal Pharm...
09/04/2025 11:27:16

HC Wainwright & Co. analyst Andrew S. Fein assumes Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy rating and announce...

gyre-therapeutics-gains-attention-as-under-the-radar-liver-fibrosis-drug-maker

Gyre Therapeutics Gains Attention As Under...
08/26/2025 18:53:44

HC Wainwright starts Gyre Therapeutics coverage with a Buy rating, citing hydronidone's $6 billion potential and strong fib...

Madrigal Pharmaceuticals Stock: A Deep Div...
08/26/2025 12:00:39

TD Cowen Maintains Buy on Madrigal Pharmac...
08/26/2025 10:31:21

TD Cowen analyst Ritu Baral maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $39...

JMP Securities Maintains Market Outperform...
08/20/2025 11:54:07

JMP Securities analyst Jonathan Wolleben maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Market Outperform and raise...

Madrigal Receives EC Conditional Approval ...
08/19/2025 20:10:02

Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing au...

novo-nordisks-wegovy-snags-conditional-fda-nod-for-fatty-liver-disease

Novo Nordisk's Wegovy Snags Conditional FD...
08/18/2025 10:16:58

FDA approves Novo Nordisk's Wegovy for MASH with liver fibrosis, supported by ESSENCE trial data as the company projects lo...

billionaire-investor-buys-google-and-this-gold-miner-stock

Billionaire Investor Buys Google And This ...
08/16/2025 17:46:39

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

UBS Maintains Buy on Madrigal Pharmaceutic...
08/12/2025 14:13:26

UBS analyst Eliana Merle maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $458 t...

Canaccord Genuity Maintains Buy on Madriga...
08/06/2025 18:03:04

Canaccord Genuity analyst Edward Nash maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price targe...